Bernhard Reis
Biomarker Lead,
F. Hoffmann-La Roche Ltd.
Brian Lockhart
Global Head of Companion Diagnostics,
Servier Monde
Bruno Gomes
Head of Early Biomarker Development Oncology,
Hoffmann La Roche Ltd
Dylan Powell
AP Public Health & Innovation,
University of Stirling
Ed Schuuring
Clinical Scientist in Molecular Pathology,
umcg
Fatima Sanfourche
Senior Director of QA & RA Compliance for Medical Devices and eHealth,
Bayer
Gro Live Fagereng
Project Manager of the EU-project PRIME-ROSE and Coordinator Precision Cancer Medicine at OUH Centre for Precision Cancer Medicine,
Oslo universitetssykehus
Guillaume Desachy
Head Of Biometrics,
AstraZeneca
Gunther Jansen
Senior Director, Precision Medicine and Data Science,
Novartis
Jacques Colinge
Professor,
University of Montpellier, France
Joanna Janus
Research Programme Manager (Early Detection and Prevention),
Cancer Research UK
Jon Krell
Senior Clinical Lecturer and Honorary Consultant in Medical Oncology,
Imperial College London
Michael Cannarile
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
China Innovation Center of Roche
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Olga Nissan
CEO,
Protica Bio
.png)